| CD81323
|
chronic hepatitis C |
blood plasma |
| CD63, caveolin-1, TYRP2, VLA-4, HSP70, HSP9037,321
|
melanoma |
blood plasma |
| epidermal
growth factor receptor VIII33
|
glioblastoma |
blood plasma |
| survivin336
|
prostate cancer |
blood plasma |
| c-src337
|
plasma cell dyscrasias |
blood plasma |
| NY-ESO-1338
|
lung cancer |
blood plasma |
| PKG1, RALGAPA2, NFX1,
TJP2339
|
breast cancer |
blood plasma |
| Her2340
|
breast cancer |
blood plasma |
| glypican-143
|
breast cancer |
blood
serum |
| glypican-143
|
pancreatic cancer |
blood serum |
| glypican-1341
|
colorectal cancer |
blood plasma |
| CEA342
|
colorectal cancer |
blood serum |
| AMPN VNN1, PIGR343
|
cholangiocarcinoma |
blood serum |
| PSA344
|
prostate cancer |
blood plasma |
| GGT1345
|
prostate cancer |
blood serum |
| CD24, EpCAM, CA-125346
|
ovarian cancer |
blood plasma |
| CD91347
|
lung cancer |
blood serum |
| TSPAN8, CD151348
|
lung
cancer |
blood plasma |
| CD82349
|
breast cancer |
blood
serum |
| CD9, CD147350
|
colorectal cancer |
blood serum |
| TSPAN8351
|
pancreatic cancer |
blood serum |
| fetuin-A, ATF 3332,352
|
acute kidney
injury |
urine |
| CD26, CD81, S1c3A1,
CD10353
|
liver injury |
urine |
| NKCC2354
|
Bartter syndrome type 1 |
urine |
| EGF, α subunit of Gs,
resisitin, retinoic acid-induced protein 3333
|
bladder cancer |
urine |
| PSA, PCA3, ERG, SPDEF334,355
|
prostate cancer |
urine |
| L1CAM, CD24, ADAM10, EMMPRIN, claudin356,357
|
ovarian cancer |
blood plasma, cell culture
medium, ascites |
| A2M, HPA, MUC5B, LGALS3BP,
IGHA1, PIP, PKM1/M2, GAPDH358
|
squamous cell carcinoma |
saliva |
| Annexin Al, A2, A3, A5, A6,
All, NPRL2, CEACAM1, HIST1H4A,
MUC1, PROM1, TNFAIP3359
|
lung
cancer |
saliva |
| LMP1, galectin-9, BARF-1360
|
nasopharyngeal cancer |
blood, saliva |
| CALML5, KRT6A, and S100P361
|
dry eye disease |
tears |
